PathGen Diagnostik Teknologi

|
Press Release

PathGen raises funding from East Ventures and Royal Group Indonesia, making early disease detection and precision medicine more accessible

PathGen or PathGen Diagnostik Teknologi, an Indonesia-based healthcare biotechnology startup specializing in molecular testing solutions, announced today that it has raised funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm in Indonesia and Southeast Asia, and Royal Group Indonesia, a dynamic and…